Literature DB >> 17054416

Metabolic profiling technologies for biomarker discovery in biomedicine and drug development.

Götz Schlotterbeck1, Alfred Ross, Frank Dieterle, Hans Senn.   

Abstract

The state-of-the-art of nuclear magnetic resonance spectroscopy, mass spectrometry and statistical tools for the acquisition and evaluation of complex multidimensional spectroscopic data in metabolic profiling is reviewed in this article. The continuous evolution of the sensitivity, precision and throughput has made these technologies powerful and extremely robust tools for application in systems biology, pharmaceutical and diagnostics research. Particular emphasis is also given to the collection and storage of biological samples that are subjected to metabolite profiling. Selected examples from preclinical and clinical applications are paradigmatically shown. These illustrate the power of the profiling technologies for characterizing the metabolic phenotype of healthy, diseased and treated subjects. The complexity of disease and drug treatment is asking for an adequate response by integrated and comprehensive metabolite profiling approaches that allow the discovery of new combinations of metabolic biomarkers.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17054416     DOI: 10.2217/14622416.7.7.1055

Source DB:  PubMed          Journal:  Pharmacogenomics        ISSN: 1462-2416            Impact factor:   2.533


  23 in total

Review 1.  Stable isotope-resolved metabolomics and applications for drug development.

Authors:  Teresa W-M Fan; Pawel K Lorkiewicz; Katherine Sellers; Hunter N B Moseley; Richard M Higashi; Andrew N Lane
Journal:  Pharmacol Ther       Date:  2011-12-23       Impact factor: 12.310

Review 2.  Database resources in metabolomics: an overview.

Authors:  Eden P Go
Journal:  J Neuroimmune Pharmacol       Date:  2009-05-07       Impact factor: 4.147

Review 3.  Emerging applications of metabolomics in studying chemopreventive phytochemicals.

Authors:  Lei Wang; Chi Chen
Journal:  AAPS J       Date:  2013-06-22       Impact factor: 4.009

4.  The application of micro-coil NMR probe technology to metabolomics of urine and serum.

Authors:  John H Grimes; Thomas M O'Connell
Journal:  J Biomol NMR       Date:  2011-03-06       Impact factor: 2.835

Review 5.  The re-emergence of natural products for drug discovery in the genomics era.

Authors:  Alan L Harvey; RuAngelie Edrada-Ebel; Ronald J Quinn
Journal:  Nat Rev Drug Discov       Date:  2015-01-23       Impact factor: 84.694

6.  Increased levels of urinary phenylacetylglycine associated with mitochondrial toxicity in a model of drug-induced phospholipidosis.

Authors:  Lucette Doessegger; Georg Schmitt; Barbara Lenz; Holger Fischer; Götz Schlotterbeck; Elke-Astrid Atzpodien; Hans Senn; Laura Suter; Miklos Csato; Stefan Evers; Thomas Singer
Journal:  Ther Adv Drug Saf       Date:  2013-06

7.  Elevated pro-inflammatory and lipotoxic mucosal lipids characterise irritable bowel syndrome.

Authors:  Kajsa Kajander; Eveliina Myllyluoma; Sinikka Kyrönpalo; Martin Rasmussen; Pentti Sipponen; Ismo Mattila; Tuulikki Seppänen-Laakso; Heikki Vapaatalo; Matej Oresic; Riitta Korpela
Journal:  World J Gastroenterol       Date:  2009-12-28       Impact factor: 5.742

8.  Stable isotope-labeled tracers for metabolic pathway elucidation by GC-MS and FT-MS.

Authors:  Richard M Higashi; Teresa W-M Fan; Pawel K Lorkiewicz; Hunter N B Moseley; Andrew N Lane
Journal:  Methods Mol Biol       Date:  2014

9.  Human cytochrome P450 4F11: heterologous expression in bacteria, purification, and characterization of catalytic function.

Authors:  Zhongmei Tang; Sandra Giovanna Salamanca-Pinzón; Zhong-Liu Wu; Yi Xiao; F Peter Guengerich
Journal:  Arch Biochem Biophys       Date:  2009-11-20       Impact factor: 4.013

Review 10.  LC-MS-based metabolomics in drug metabolism.

Authors:  Chi Chen; Frank J Gonzalez; Jeffrey R Idle
Journal:  Drug Metab Rev       Date:  2007       Impact factor: 4.518

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.